Marstacimab, an Anti-Tissue Factor Pathway Inhibitor, in Participants with Hemophilia. or B, with and without Inhibitors: An Integrated Analysis of Safety-MedSci.cn

Marstacimab, an Anti-Tissue Factor Pathway Inhibitor, in Participants with Hemophilia. or B, with and without Inhibitors: An Integrated Analysis of Safety

Acharya, S; Matino, D; Mahlangu, J; Turich, C; Hwang, E; Hinnershitz, T; Mefyod, E; Palladino, A; Biondo, F; Gould, T; Teeter, J

BLOOD, 2023; 142 ():

科室
- - 订阅+
  - 更多科室
工具
服务